Patents by Inventor Charles R. Valliere

Charles R. Valliere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and composition for treating or preventing osteoporosis
    Patent number: 6150346
    Abstract: Method of treating or preventing osteoporosis by administering orally a 1.alpha.-hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1.alpha.-hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 21, 2000
    Assignee: Bone Care International, Inc.
    Inventors: Joyce C. Knutson, Charles W. Bishop, Charles R. Valliere
  • Oral 1.alpha.-hydroxyprevitamin D in composition and method for treating psoriasis
    Patent number: 6147064
    Abstract: Method of treating psoriasis by administering orally a 1.alpha.-hydroxyprevitamin D. This previtamin D form treats psoriasis without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1.alpha.-hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 14, 2000
    Assignee: Bone Care International, Inc.
    Inventors: Joyce C. Knutson, Charles R. Valliere, Charles W. Bishop
  • Oral 1.alpha.-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
    Patent number: 6133250
    Abstract: Method of increasing activated vitamin D blood level by administering orally a 1.alpha.-hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1.alpha.-hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: October 17, 2000
    Assignee: Bone Care International, Inc.
    Inventors: Joyce C. Knutson, Charles W. Bishop, Charles R. Valliere
  • Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
    Patent number: 5795882
    Abstract: Method of treating prostatic conditions such as prostate cancer and hyperplasia by administering 1.alpha.-hydroxyprevitamin D or activated vitamin D or a combination thereof in a sustained release form or a delayed and sustained release formulation. Both the sustained release form and the delayed, sustained release form deliver increased active vitamin D blood levels without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms, to provide the beneficial effect to the diseased prostate tissue.
    Type: Grant
    Filed: December 30, 1996
    Date of Patent: August 18, 1998
    Assignee: Bone Care International, Inc.
    Inventors: Charles W. Bishop, Joyce C. Knutson, Charles R. Valliere
  • Oral 1 .alpha.-hydroxyprevitamin D
    Patent number: 5622941
    Abstract: Method of increasing activated vitamin D blood level by administering orally a 1.alpha.-hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1.alpha.-hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: January 26, 1994
    Date of Patent: April 22, 1997
    Assignee: Lunar Corporation
    Inventors: Joyce C. Knutson, Charles W. Bishop, Charles R. Valliere
  • Oral 1.alpha.-hydroxyprevitamin D
    Patent number: 5614513
    Abstract: Method of increasing activated vitamin D blood level by administering orally a 1.alpha.-hydroxyprevitamin D or a delayed and sustained release formulation of activated vitamin D or a combination thereof. Both the previtamin D form and the delayed and sustained release activated vitamin D formulation increase vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 25, 1997
    Assignee: Bone Care International, Inc.
    Inventors: Joyce C. Knutson, Charles W. Bishop, Charles R. Valliere
  • Oral 1.alpha.-hydroxyprevitamin D
    Patent number: 5529991
    Abstract: This invention relates to delayed and sustained release oral medicaments and, more specifically, to delayed and sustained release activated vitamin D, oral medicament.
    Type: Grant
    Filed: February 22, 1994
    Date of Patent: June 25, 1996
    Assignee: Lunar Corporation
    Inventors: Joyce C. Knutson, Charles R. Valliere, Charles W. Bishop